The Role of AMPKα2 in the HFD-induced Nonalcoholic Steatohepatitis.

Xuejiao Zhang,Sasa Liu,Chang Zhang,Shitian Zhang,Yingying Yue,Youyi Zhang,Liming Chen,Zhi Yao,Wenyan Niu

DOI: https://doi.org/10.1016/j.bbadis.2020.165854

2020-01-01

Abstract:Nonalcoholic fatty liver disease (NAFLD) is associated with hepatic steatosis, inflammation and liver fibrosis and has become one of the leading causes of hepatocellular carcinoma and liver failure. However, the underlying molecular mechanism of hepatic steatosis and the progression to nonalcoholic steatohepatitis (NASH) are not fully understood. Herein, we discovered that AMPK alpha 2 catalytic subunit showed reduced expression in the liver following high fat diet (HFD) feeding to mice. Importantly, knockout of AMPK alpha 2 in mice aggravated NAFLD, hepatic steatosis, inflammation and fibrosis. On the other hand, hepatocyte-targeted overexpression of AMPK alpha 2 prevented or reversed NAFLD indications. In vivo mechanistic studies revealed that increased phosphorylation of IKK alpha/beta and NF-kappa B in HFD-fed AMPK alpha 2(-/-) mice compared to WT mice, and treatment of these mouse cohorts with an inhibitor of NF-kappa B signaling for 4 weeks, effectively attenuated the progression of steatohepatitis and metabolic disorder features. In summary, AMPK alpha 2 provides a protective role in the process of hepatic steatosis to NASH progression through suppression of liver NF-kappa B signaling.